Mechanism of action of venetoclax (ABT-199) and its side effects
The current status of CLL treatment
What can clonal evolution in chronic lymphocytic leukemia (CLL) tell us about outcomes?
FCR or FR – which regimen is better for treating CLL?
Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.